American Journal of Transplantation, 1600-6135

Tidskrift

Fler filtreringsmöjligheter
  1. 2018
  2. Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients

    Tomas Lorant, Mats Bengtsson, Torsten Eich, Britt Marie Eriksson, Lena Winstedt, Sofia Järnum, Yvonne Stenberg, Anna Karin Robertson, Kristina Mosén, Lars Björck, Lars Bäckman, Erik Larsson, Kathryn Wood, Gunnar Tufveson & Christian Kjellman, 2018 nov, I : American Journal of Transplantation. 18, 11, s. 2752-2762

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Heparin-binding protein, lysozyme, and inflammatory cytokines in bronchoalveolar lavage fluid as diagnostic tools for pulmonary infection in lung transplanted patients

    Anna Stjärne Aspelund, Helena Hammarström, Malin Inghammar, Hillevi Larsson, Lennart Hansson, Bertil Christensson & Lisa I. Påhlman, 2018, I : American Journal of Transplantation. 18, 2, s. 444-452

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. 2016
  5. Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study.

    A K Andreassen, B Andersson, F Gustafsson, H Eiskjaer, Göran Rådegran, E Gude, K Jansson, D Solbu, K Karason, S Arora, G Dellgren & L Gullestad, 2016 apr, I : American Journal of Transplantation. 16, 4, s. 1238-1247 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Altered Immunogenicity of Donor Lungs via Removal of Passenger Leukocytes Using Ex Vivo Lung Perfusion.

    J P Stone, W R Critchley, T Major, G Rajan, I Risnes, H Scott, Qiuming Liao, Björn Wohlfart, Trygve Sjöberg, N Yonan, Stig Steen & J E Fildes, 2016, I : American Journal of Transplantation. 16, 1, s. 33-43

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2015
  8. Genetic variation in caveolin-1 correlates with long-term pancreas transplant function

    A Hamilton, S Mittal, M C N M Barnardo, S V Fuggle, P Friend, S C L Gough & M J Simmonds, 2015 maj, I : American Journal of Transplantation. 15, 5, s. 1392-1399 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial

    S. Arora, A. K. Andreassen, B. Andersson, F. Gustafsson, H. Eiskjaer, H. E. Botker, Göran Rådegran, E. Gude, D. Ioanes, D. Solbu, V. Sigurdardottir, G. Dellgren, I. Erikstad, O. G. Solberg, T. Ueland, P. Aukrust & L. Gullestad, 2015, I : American Journal of Transplantation. 15, 7, s. 1967-1975

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. 2014
  11. Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial

    A. K. Andreassen, B. Andersson, F. Gustafsson, H. Eiskjaer, Göran Rådegran, E. Gude, K. Jansson, D. Solbu, V. Sigurdardottir, S. Arora, G. Dellgren & L. Gullestad, 2014, I : American Journal of Transplantation. 14, 8, s. 1828-1838

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. 2013
  13. Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical Trials

    R. Bouamar, N. Shuker, D. A. Hesselink, W. Weimar, Henrik Ekberg, B. Kaplan, C. Bernasconi & T. van Gelder, 2013, I : American Journal of Transplantation. 13, 5, s. 1253-1261

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. 2012
  15. Virtual Histology Assessment of Cardiac Allograft Vasculopathy Following Introduction of Everolimus-Results of a Multicenter Trial.

    S Arora, I Erikstad, T Ueland, V Sigurdardottir, Björn Ekmehag, Kristina Jansson, H Eiskjaer, H E Bøtker, S-A Mortensen, K Saunamaki, E Gude, A Ragnarsson, D Solbu, P Aukrust & L Gullestad, 2012, I : American Journal of Transplantation. 12, 10, s. 2700-2709

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. 2010
  17. Is Rituximab Safe to Use in Kidney Transplant Patients?

    G. Tyden, L. Mjornstedt, Henrik Ekberg & G. Tufveson, 2010, I : American Journal of Transplantation. 10, 8, s. 1949-1949

    Forskningsoutput: TidskriftsbidragLetter

  18. 2009
  19. Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after Transplantation.

    Henrik Ekberg, C Bernasconi, H Tedesco-Silva, S Vítko, C Hugo, A Demirbas, R Reyes Acevedo, J Grinyó, U Frei, Y Vanrenterghem, P Daloze & P Halloran, 2009, I : American Journal of Transplantation. 9, s. 1876-1885

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Subgroup Analyses in Randomized Controlled Trials: The Need for Risk Stratification in Kidney Transplantation

    M. Wagner, E. M. Balk, D. M. Kent, B. L. Kasiske & Henrik Ekberg, 2009, I : American Journal of Transplantation. 9, 10, s. 2217-2222

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  21. 2008
  22. Can DXA Predict Fractures in Renal Transplant Patients?

    Shahriar Akaberi, Ole Simonsen, Birger Lindergård & G Nyberg, 2008, I : American Journal of Transplantation. 8, 12, s. 2647-2651

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. CNI sparing in de novo renal transplantation: 3-year results from the symphony study

    Henrik Ekberg, H Tedesco-Silva, A Demirbas, S Vitko, J Klempnauer, A Gurkan, R Margreiter, C Hugo, J Grinyo, U Frei, Y Vanrenterghem, P Daloze & P Halloran, 2008, I : American Journal of Transplantation. 8, s2, s. 336-336

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  24. Improved outcomes after De Novo renal transplantation: 2-year results from the symphony study

    Henrik Ekberg, H Tedesco-Silva, A Demirbas, S Vitko, J Klempnauer, A Gurkan, R Margreiter, C Hugo, J Grinyo, U Frei, Y Vanrenterghem, P Daloze & P Halloran, 2008, I : American Journal of Transplantation. 8, s2, s. 320-320

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  25. 2007
  26. Cyclosporine Sparing with Mycophenolate Mofetil, Daclizumab and Corticosteroids in Renal Allograft Recipients: The CAESAR Study.

    Henrik Ekberg, J Grinyó, B Nashan, Y Vanrenterghem, F Vincenti, A Voulgari, M Truman, C Nasmyth-Miller & M Rashford, 2007, I : American Journal of Transplantation. 7, 3, s. 560-570

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. 2005
  28. Minimization of immunosuppressive therapy after renal transplantation: Results of a randomized controlled trial

    Y Vanrenterghem, JP van Hooff, JP Squifflet, K Salmela, P Rigotti, RM Jindal, J Pascual, Henrik Ekberg, LS Sicilia, JN Boletis, JM Grinyo & MA Rodriguez, 2005, I : American Journal of Transplantation. 5, 1, s. 87-95

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. 2002
  30. Estimated and measured donor creatinine clearance are poor predictors of long-term renal graft function and survival

    E Pokorna, O Schuck, S Vitko & Henrik Ekberg, 2002, I : American Journal of Transplantation. 2, 4, s. 373-380

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift